Skip to content

Economic Analysis of Robotic Rectal Resection in German Health Care System

Economic Analysis of Robotic Rectal Resection in German Health Care System

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06113796
Enrollment
65
Registered
2023-11-02
Start date
2018-01-01
Completion date
2021-12-31
Last updated
2023-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal Cancer

Keywords

Robotic Surgery, Rectal Cancer, Low anterior Resection, Abdominoperineal rectal extirpation, Economic analysis

Brief summary

Analysis of cost effectiveness of robotic rectal resection, either sphincter preserving or abdominoperineal extirpation, in the German diagnosis related groups (DRG) system.

Detailed description

Robotic surgery has many well-known benefits for patients and surgeons, while it comes with higher acquisition and maintenance costs. On the other hand, a higher proportion of minimally invasive procedures can save costs by reducing complications, decreasing hospital stays due to lower morbidity, and saving personnel. To what extent can robotic surgery be cost-covering or even profitable, depending on the postoperative course? This question is investigated under the conditions of the German DRG system.

Interventions

OTHERSurgery

Robotic rectal resection, either sphincter preserving or extirpation

Sponsors

Universitätsklinikum Hamburg-Eppendorf
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18y * histologically proven rectal cancer with curative therapeutic approach * suitable for minimally-invasive surgery

Exclusion criteria

* no rectal cancer * primary open surgery

Design outcomes

Primary

MeasureTime frameDescription
Costs of treatment1 yearcosts caused by the case

Secondary

MeasureTime frameDescription
Major Complication30 days postoperativelyClavin Dindo Score ≥ 3
Length of Hospital Stay3 monthsHospital Stay after Surgery
30-days Readmission30 daysReadmission within 30 days after Surgery

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026